TY - JOUR
T1 - hiPSC-Derived Epidermal Keratinocytes from Ichthyosis Patients Show Altered Expression of Cornification Markers
AU - De Lima Cunha, Dulce
AU - Oram, Amanda
AU - Gruber, Robert
AU - Plank, Roswitha
AU - Lingenhel, Arno
AU - Gupta, Manoj K
AU - Altmüller, Janine
AU - Nürnberg, Peter
AU - Schmuth, Matthias
AU - Zschocke, Johannes
AU - Šarić, Tomo
AU - Eckl, Katja Martina
AU - Hennies, Hans
N1 - Funding Information:
Funding: This research was supported in part by funds from the German Federal Ministry for Education and Research (E-Rare-2 01GM1201 to H.C.H.), the Köln Fortune Programme (to T.Š. and H.C.H.), the Austrian Science Fund (I2259-B26 to H.C.H.) and the Austrian National Bank (OeNB 15620 to H.C.H.). Open Access Funding by the Austrian Science Fund (FWF).
Funding Information:
This research was supported in part by funds from the German Federal Ministry for Education and Research (E-Rare-2 01GM1201 to H.C.H.), the K?ln Fortune Programme (to T.?. and H.C.H.), the Austrian Science Fund (I2259-B26 to H.C.H.) and the Austrian National Bank (OeNB 15620 to H.C.H.). Open Access Funding by the Austrian Science Fund (FWF).
Publisher Copyright:
© 2021 by the authorsLicensee MDPI, Basel, Switzerland.
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/2/11
Y1 - 2021/2/11
N2 - Inherited ichthyoses represent a large heterogeneous group of skin disorders characterised by impaired epidermal barrier function and disturbed cornification. Current knowledge about disease mechanisms has been uncovered mainly through the use of mouse models or human skin organotypic models. However, most mouse lines suffer from severe epidermal barrier defects causing neonatal death and human keratinocytes have very limited proliferation ability in vitro. Therefore, the development of disease models based on patient derived human induced pluripotent stem cells (hiPSCs) is highly relevant. For this purpose, we have generated hiPSCs from patients with congenital ichthyosis, either non-syndromic autosomal recessive congenital ichthyosis (ARCI) or the ichthyosis syndrome trichothiodystrophy (TTD). hiPSCs were successfully differentiated into basal keratinocyte-like cells (hiPSC-bKs), with high expression of epidermal keratins. In the presence of higher calcium concentrations, terminal differentiation of hiPSC-bKs was induced and markers KRT1 and IVL expressed. TTD1 hiPSC-bKs showed reduced expression of FLG, SPRR2B and lipoxygenase genes. ARCI hiPSC-bKs showed more severe defects, with downregulation of several cornification genes. The application of hiPSC technology to TTD1 and ARCI demonstrates the successful generation of in vitro models mimicking the disease phenotypes, proving a valuable system both for further molecular investigations and drug development for ichthyosis patients
AB - Inherited ichthyoses represent a large heterogeneous group of skin disorders characterised by impaired epidermal barrier function and disturbed cornification. Current knowledge about disease mechanisms has been uncovered mainly through the use of mouse models or human skin organotypic models. However, most mouse lines suffer from severe epidermal barrier defects causing neonatal death and human keratinocytes have very limited proliferation ability in vitro. Therefore, the development of disease models based on patient derived human induced pluripotent stem cells (hiPSCs) is highly relevant. For this purpose, we have generated hiPSCs from patients with congenital ichthyosis, either non-syndromic autosomal recessive congenital ichthyosis (ARCI) or the ichthyosis syndrome trichothiodystrophy (TTD). hiPSCs were successfully differentiated into basal keratinocyte-like cells (hiPSC-bKs), with high expression of epidermal keratins. In the presence of higher calcium concentrations, terminal differentiation of hiPSC-bKs was induced and markers KRT1 and IVL expressed. TTD1 hiPSC-bKs showed reduced expression of FLG, SPRR2B and lipoxygenase genes. ARCI hiPSC-bKs showed more severe defects, with downregulation of several cornification genes. The application of hiPSC technology to TTD1 and ARCI demonstrates the successful generation of in vitro models mimicking the disease phenotypes, proving a valuable system both for further molecular investigations and drug development for ichthyosis patients
KW - Autosomal recessive
KW - Congenital ichthyosis
KW - Cornification
KW - Disease modelling
KW - Epidermal barrier function
KW - Induced pluripotent stem cells
KW - Trichothiodystrophy
KW - Autosomal recessive congenital ichthyosis
UR - http://www.scopus.com/inward/record.url?scp=85100670223&partnerID=8YFLogxK
U2 - 10.3390/ijms22041785
DO - 10.3390/ijms22041785
M3 - Article
VL - 22
SP - 1
EP - 16
JO - International Journal of Molecular Sciences
JF - International Journal of Molecular Sciences
SN - 1661-6596
IS - 4
M1 - 1785
ER -